» Articles » PMID: 23469847

Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases

Overview
Specialties Neurology
Pharmacology
Date 2013 Mar 9
PMID 23469847
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

In the past decade, evidence has emerged that there is a variety of bidirectional cell-cell and/or cell-extracellular matrix interactions within the neurovascular unit (NVU), which is composed of neuronal, glial, and vascular cells along with extracellular matrix. Many central nervous system diseases, which lead to NVU dysfunction, have common features such as glial activation/transformation and vascular/blood-brain-barrier alteration. These phenomena show dual opposite roles, harmful at acute phase and beneficial at chronic phase. This diverse heterogeneity may induce biphasic clinical courses, i.e. degenerative and regenerative processes in the context of dynamically coordinated cellcell/ cell-matrix interactions in the NVU. A deeper understanding of the seemingly contradictory actions in cellular levels is essential for NVU protection or regeneration to suppress the deleterious inflammatory reactions and promote adaptive remodeling after central nervous system injury. This mini-review will present an overview of recent progress in the biphasic roles of the NVU and discuss the clinical relevance of NVU responses associated with central nervous system diseases, such as stroke and other chronic neurodegenerative diseases.

Citing Articles

BDNF Signaling in Vascular Dementia and Its Effects on Cerebrovascular Dysfunction, Synaptic Plasticity, and Cholinergic System Abnormality.

Song J J Lipid Atheroscler. 2024; 13(2):122-138.

PMID: 38826183 PMC: 11140249. DOI: 10.12997/jla.2024.13.2.122.


Microglia in Ischemic Stroke: Pathogenesis Insights and Therapeutic Challenges.

Shui X, Chen J, Fu Z, Zhu H, Tao H, Li Z J Inflamm Res. 2024; 17:3335-3352.

PMID: 38800598 PMC: 11128258. DOI: 10.2147/JIR.S461795.


Sustained Retinal Defocus Increases the Effect of Induced Myopia on the Retinal Astrocyte Template.

Lin C, Toychiev A, Ablordeppey R, Srinivas M, Benavente-Perez A Cells. 2024; 13(7.

PMID: 38607034 PMC: 11011523. DOI: 10.3390/cells13070595.


The role of oxidative stress in blood-brain barrier disruption during ischemic stroke: Antioxidants in clinical trials.

Lochhead J, Ronaldson P, Davis T Biochem Pharmacol. 2024; 228:116186.

PMID: 38561092 PMC: 11410550. DOI: 10.1016/j.bcp.2024.116186.


Micro-ultrasound based characterization of cerebrovasculature following focal ischemic stroke and upon short-term rehabilitation.

Yu J, Joo I, Bazzigaluppi P, Koletar M, Cherin E, Stanisz A J Cereb Blood Flow Metab. 2023; 44(4):461-476.

PMID: 37974304 PMC: 10981404. DOI: 10.1177/0271678X231215004.


References
1.
Dauer W, Przedborski S . Parkinson's disease: mechanisms and models. Neuron. 2003; 39(6):889-909. DOI: 10.1016/s0896-6273(03)00568-3. View

2.
Krupinski J, Kaluza J, Kumar P, Kumar S, Wang J . Some remarks on the growth-rate and angiogenesis of microvessels in ischemic stroke. Morphometric and immunocytochemical studies. Patol Pol. 1993; 44(4):203-9. View

3.
Kokovay E, Goderie S, Wang Y, Lotz S, Lin G, Sun Y . Adult SVZ lineage cells home to and leave the vascular niche via differential responses to SDF1/CXCR4 signaling. Cell Stem Cell. 2010; 7(2):163-73. PMC: 2916873. DOI: 10.1016/j.stem.2010.05.019. View

4.
Leys D, Henon H, Mackowiak-Cordoliani M, Pasquier F . Poststroke dementia. Lancet Neurol. 2005; 4(11):752-9. DOI: 10.1016/S1474-4422(05)70221-0. View

5.
Ikonomidou C, Turski L . Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?. Lancet Neurol. 2003; 1(6):383-6. DOI: 10.1016/s1474-4422(02)00164-3. View